Lifecore Biomedical Inc (NASDAQ: LFCR) stock closed at $4.74 on 8/27/24 after a major decline of -25.2%. Moreover, trading volume in this decline was exceptionally high at 827% of normal. The stock has declined -15.4% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
LFCR’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
Lifecore Biomedical is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment